(Q42463384)

1 November 2017

Effect of histone deacetylase inhibitor JNJ-26481585 in pain (English)

1 reference

1 November 2017

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25085711%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

author name string

Kathryn E Capasso

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25085711%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Melissa T Manners

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25085711%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Rehman A Quershi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25085711%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Yuzhen Tian

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25085711%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Ruby Gao

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25085711%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

James E Barrett

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25085711%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Ahmet Sacan

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25085711%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Seena K Ajit

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25085711%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

publication date

2 August 2014

1 reference

Journal of Molecular Neuroscience

1 November 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25085711%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

volume

55

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25085711%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25085711%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

page(s)

570-578

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25085711%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s12031-014-0391-7

1 June 2020

exact match

0 references

cites work

Histone/protein deacetylases and T-cell immune responses

1 reference

https://api.crossref.org/works/10.1007%2FS12031-014-0391-7

JNJ-26481585, a novel "second-generation" oral histone deacetylase inhibitor, shows broad-spectrum preclinical antitumoral activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-014-0391-7

The neuro-immune balance in neuropathic pain: involvement of inflammatory immune cells, immune-like glial cells and cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-014-0391-7

Inhibition of class II histone deacetylases in the spinal cord attenuates inflammatory hyperalgesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-014-0391-7

Histone deacetylase activities are required for innate immune cell control of Th1 but not Th2 effector cell function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-014-0391-7

Epigenetic modulation of mGlu2 receptors by histone deacetylase inhibitors in the treatment of inflammatory pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-014-0391-7

Cancer pain and analgesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-014-0391-7

HDAC inhibitors attenuate the development of hypersensitivity in models of neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-014-0391-7

Chronic pain: emerging evidence for the involvement of epigenetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-014-0391-7

Epigenetics in pain and analgesia: an imminent research field

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-014-0391-7

Mechanical allodynia induced by paclitaxel, oxaliplatin and vincristine: different effectiveness of gabapentin and different expression of voltage-dependent calcium channel alpha(2)delta-1 subunit

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-014-0391-7

Targeting epigenetic mechanisms for pain relief

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-014-0391-7

Guidance molecules in axon regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-014-0391-7

Assessment and treatment of neuropathic cancer pain following WHO guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-014-0391-7

The many roles of histone deacetylases in development and physiology: implications for disease and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-014-0391-7

Differential effects of selective HDAC inhibitors on macrophage inflammatory responses to the Toll-like receptor 4 agonist LPS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-014-0391-7

The Gene Ontology (GO) database and informatics resource

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-014-0391-7

The kv4.2 potassium channel subunit is required for pain plasticity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-014-0391-7

Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-014-0391-7

Exploring the neuroimmunopharmacology of opioids: an integrative review of mechanisms of central immune signaling and their implications for opioid analgesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-014-0391-7

Exploration, normalization, and summaries of high density oligonucleotide array probe level data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-014-0391-7

Mechanisms in cancer-chemotherapeutic drugs-induced peripheral neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-014-0391-7

Therapy of chemotherapy-induced peripheral neuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-014-0391-7

KEGG: kyoto encyclopedia of genes and genomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-014-0391-7

Bidirectional modulation of synaptic functions by Eph/ephrin signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-014-0391-7

SnapShot: Histone-modifying enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-014-0391-7

Management of chronic pain in cancer survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-014-0391-7

Epigenetic regulation of opioid-induced hyperalgesia, dependence, and tolerance in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-014-0391-7

Inhibition of paclitaxel-induced A-fiber hypersensitization by gabapentin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-014-0391-7

Novel roles for Slits and netrins: axon guidance cues as anticancer targets?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-014-0391-7

Chemotherapy-induced peripheral neuropathy: prevention and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-014-0391-7

Mechanisms underlying chemotherapy-induced neurotoxicity and the potential for neuroprotective strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-014-0391-7

Semaphorin function in neural plasticity and disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-014-0391-7

Histone deacetylase inhibitors impair innate immune responses to Toll-like receptor agonists and to infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-014-0391-7

Analyzing real-time PCR data by the comparative C(T) method

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-014-0391-7

Histone deacetylases as regulators of inflammation and immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-014-0391-7

HDAC inhibitors: modulating leukocyte differentiation, survival, proliferation and inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-014-0391-7

Preclinical antileukemia activity of JNJ-26481585, a potent second-generation histone deacetylase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-014-0391-7

Importance of epigenetic mechanisms in visceral pain induced by chronic water avoidance stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-014-0391-7

Chemotherapy-induced peripheral neuropathy: prevention and treatment strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-014-0391-7

Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-014-0391-7

Epigenetic suppression of GAD65 expression mediates persistent pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-014-0391-7

Histone deacetylase inhibitors decrease Toll-like receptor-mediated activation of proinflammatory gene expression by impairing transcription factor recruitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-014-0391-7

Potential non-oncological applications of histone deacetylase inhibitors

21 January 2018

1 reference

12 December 2020

Chemotherapy-evoked painful peripheral neuropathy

1 reference

12 December 2020

A phase I study of quisinostat (JNJ-26481585), an oral hydroxamate histone deacetylase inhibitor with evidence of target modulation and antitumor activity, in patients with advanced solid tumors.

1 reference

12 December 2020

Chemotherapy-induced peripheral neurotoxicity

1 reference

12 December 2020

Chemotherapy-induced peripheral neuropathy

1 reference

12 December 2020

Epigenetic Augmentation of the Macrophage Inflammatory Protein 2/C-X-C Chemokine Receptor Type 2 Axis through Histone H3 Acetylation in Injured Peripheral Nerves Elicits Neuropathic Pain

1 reference

12 December 2020